Clinical Trial Update: Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis

View source ↗

Summary

This clinical trial studies multimodal imaging to uncover the biological mechanisms underlying neurodegeneration in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Multiple Sclerosis (MS) | Status: RECRUITING